The differences of fasting levels of ghrelin in cancer patients may be explained by differences in BMIs, 20.7 kg m−2 in LD and 20.6 kg m−2 in UD, and 18.5 kg m−2 in others (Shimizu et al, 2003). This evidence concerns the gene GHRL and cancer.